| 1. |
Leqembi |
lecanemab-irmb |
1/6/2023 |
To treat Alzheimer’s disease
Press Release |
| 2. |
Brenzavvy |
bexagliflozin |
1/20/2023 |
To improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise
Drug Trials Snapshot |
| 3. |
Jaypirca |
pirtobrutinib |
1/27/2023 |
To treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitor
Drug Trials Snapshot |
| 4. |
Orserdu |
elacestrant |
1/27/2023 |
To treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated, advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy
Drug Trials Snapshot |
| 5. |
Jesduvroq |
daprodustat |
2/1/2023 |
To treat anemia caused by chronic kidney disease for adults on dialysis for at least four months
Press Release
Drug Trials Snapshot |
| 6. |
Lamzede |
velmanase alfa-tycv |
2/16/2023 |
To treat non-central nervous system manifestations of alpha-mannosidosis |
| 7. |
Filspari |
sparsentan |
2/17/2023 |
To reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression
Drug Trials Snapshot |
| 8. |
Skyclarys |
omaveloxolone |
2/28/2023 |
To treat Friedrich’s ataxia
Drug Trials Snapshots |
| 9. |
Zavzpret |
zavegepant |
3/9/2023 |
To treat migraine |
| 10. |
Daybue |
trofinetide |
3/10/2023 |
To treat Rett syndrome
Drug Trials Snapshot |
| 11. |
Zynyz |
retifanlimab-dlwr |
3/22/2023 |
To treat metastatic or recurrent locally advanced Merkel cell carcinoma
Drug Trials Snapshot |
| 12. |
Rezzayo |
rezafungin |
3/22/2023 |
To treat candidemia and invasive candidiasis |
| 13. |
Joenja |
leniolisib |
3/24/2023 |
To treat activated phosphoinositide 3-kinase delta syndrome
Drug Trials Snapshots |
| 14. |
Qalsody |
tofersen |
4/25/2023 |
To treat amyotrophic lateral sclerosis in adults who have a SOD1 gene mutation |
| 15. |
Elfabrio |
pegunigalsidase alfa-iwxj |
5/9/2023 |
To treat confirmed Fabry disease
Drug Trials Snapshot |
| 16. |
Veozah |
fezolinetant |
5/12/2023 |
To treat moderate to severe hot flashes caused by menopause
Press Release
Drug Trials Snapshot
|
| 17. |
Miebo |
perfluorhexyloctane |
5/18/2023 |
To treat signs and symptoms of dry eye disease |
| 18. |
Epkinly |
epcoritamab-bysp |
5/19/2023 |
To treat relapsed or refractory diffuse large B-cell lymphoma (not otherwise specified) and high-grade B-cell lymphoma after two or more lines of systemic therapy
Drug Trails Snapshots |
| 19. |
Xacduro |
sulbactam, durlobactam |
5/23/2023 |
To treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex
Press Release |
| 20. |
Paxlovid |
nirmatrelvir, ritonavir |
5/25/2023 |
To treat mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19
Press Release
Drug Trials Snapshot |
| 21. |
Posluma |
flotufolastat F 18 |
5/25/2023 |
To use with positron emission tomography imaging in certain patients with prostate cancer
Drug Trials Snapshot |
| 22. |
Inpefa |
sotagliflozin |
5/26/2023 |
To treat heart failure
Drug Trials Snapshot |
| 23. |
Columvi |
glofitamab-gxbm |
6/15/2023 |
To treat diffuse large B-cell lymphoma, not otherwise specified, or large B-cell lymphoma arising from follicular lymphoma after two or more lines of systemic therapy
Drug Trials Snapshot |
| 24. |
Litfulo |
ritlecitinib |
6/23/2023 |
To treat severely patchy hair loss
Drug Trials Snapshot |
| 25. |
Rystiggo |
rozanolixizumab-noli |
6/26/2023 |
To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor- or anti-muscle-specific tyrosine kinase antibody-positive
Drug Trials Snapshot |
| 26. |
Ngenla |
somatrogon-ghla |
6/27/2023 |
To treat growth failure due to inadequate secretion of endogenous growth hormone
Drug Trials Snapshot |
| 27. |
Beyfortus |
nirsevimab-alip |
7/17/2023 |
To prevent respiratory syncytial virus (RSV) lower respiratory tract disease
Press Release
Drug Trials Snapshot |
| 28. |
Vanflyta |
quizartinib |
7/20/2023 |
To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria
Drug Trials Snapshot |
| 29. |
Xdemvy |
lotilaner |
7/25/2023 |
To treat Demodex blepharitis |
| 30. |
Zurzuvae |
zuranolone |
8/4/2023 |
To treat postpartum depression
Press Release
Drug Trials Snapshot |
| 31. |
Izervay |
avacincaptad pegol |
8/4/2023 |
To treat geographic atrophy secondary to age-related macular degeneration |
| 32. |
Talvey |
talquetamab-tgvs |
8/9/2023 |
To treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies
Drug Trials Snapshot |
| 33. |
Elrexfio |
elranatamab-bcmm |
8/14/2023 |
To treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy
Drug Trials Snapshot |
| 34. |
Sohonos |
palovarotene |
8/16/2023 |
To reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva
Drug Trials Snapshot |
| 35. |
Veopoz |
pozelimab-bbfg |
8/18/2023 |
To treat patients 1 year old and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease
Drug Trials Snapshot |
| 36. |
Aphexda |
motixafortide |
9/8/2023 |
To use with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma
Drug Trials Snapshot |
| 37. |
Ojjaara |
momelotinib |
9/15/2023 |
To treat intermediate or high-risk myelofibrosis in adults with anemia |
| 38. |
Exxua |
gepirone |
9/22/2023 |
To treat major depressive disorder |
| 39. |
Pombiliti |
cipaglucosidase alfa-atga |
9/28/2023 |
To treat late-onset Pompe disease
Drug Trials Snapshot |
| 40. |
Rivfloza |
nedosiran |
9/29/2023 |
To lower urinary oxalate levels in patients 9 years and older with primary hyperoxaluria type 1 and relatively preserved kidney function
Drug Trials Snapshot |
| 41. |
Velsipity |
etrasimod |
10/12/2023 |
To treat moderately to severely active ulcerative colitis in adults
Drug Trials Snapshot |
| 42. |
Zilbrysq |
zilucoplan |
10/17/2023 |
To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive
Drug Trials Snapshot |
| 43. |
Bimzelx |
bimekizumab |
10/17/2023 |
To treat moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy
Drug Trials Snapshot |
| 44. |
Agamree |
vamorolone |
10/26/2023 |
To treat Duchenne muscular dystrophy
Drug Trials Snapshot |
| 45. |
Omvoh |
mirikizumab-mrkz |
10/26/2023 |
To treat ulcerative colitis
Drug Trials Snapshot |
| 46. |
Loqtorzi |
toripalimab-tpzi |
10/27/2023 |
To treat recurrent or metastatic nasopharyngeal carcinoma when used together with or following other therapies |
| 47. |
Fruzaqla |
fruquintinib |
11/8/2023 |
To treat refractory, metastatic colorectal cancer
Drug Trials Snapshot |
| 48. |
Defencath |
taurolidine, heparin |
11/15/2023 |
To reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter
Drug Trials Snapshot |
| 49. |
Augtyro |
repotrectinib |
11/15/2023 |
To treat ROS1-positive non-small cell lung cancer
Drug Trials Snapshot |
| 50. |
Ryzneuta |
efbemalenograstim alfa-vuxw |
11/16/2023 |
To treat neutropenia
Drug Trials Snapshot |
| 51. |
Truqap |
capivasertib |
11/16/2023 |
To treat breast cancer that meets certain disease criteria |
| 52. |
Ogsiveo |
nirogacestat |
11/27/2023 |
To treat adults with progressing desmoid tumors who require systemic treatment
Drug Trials Snapshot |
| 53. |
Fabhalta |
iptacopan |
12/5/2023 |
To treat paroxysmal nocturnal hemoglobinuria |
| 54. |
Filsuvez |
birch triterpenes |
12/18/2023 |
To treat wounds associated with dystrophic and junctional epidermolysis bullosa
Drug Trials Snapshot |
| 55. |
Wainua |
eplontersen |
12/21/2023 |
To treat polyneuropathy of hereditary transthyretin-mediated amyloidosis
Drug Trials Snapshot |
Source
